Cargando…

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Natural killer T (NKT) cells are a unique subset of T cells that display markers characteristic of both natural killer (NK) cells and T cells(1). Unlike classical T cells, NKT cells recognize lipid antigen in the context of CD1 molecules(2). NKT cells express an invariant TCRα chain rearrangement: V...

Descripción completa

Detalles Bibliográficos
Autores principales:	East, James E., Sun, Wenji, Webb, Tonya J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MyJove Corporation 2012
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577866/ https://www.ncbi.nlm.nih.gov/pubmed/23299308 http://dx.doi.org/10.3791/4333

Ejemplares similares

Genetically modified artificial antigen-presenting cells (aAPC) for expansion of melanoma tumor infiltrating lymphocytes with optimal properties for adoptive cell therapy
por: Forget, Marie-Andrée, et al.
Publicado: (2013)

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
por: Schütz, Christian, et al.
Publicado: (2014)

A clinical grade cell-based artificial APT, aAPC/mOKT3, for unbiased expansion of CD3+ T lymphocytes
por: Sotov, Valentin, et al.
Publicado: (2014)

Evaluation of piggyBac‐mediated anti‐CD19 CAR‐T cells after ex vivo expansion with aAPCs or magnetic beads
por: Yang, Li‐Rong, et al.
Publicado: (2020)

Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy
por: Shissler, Susannah C., et al.
Publicado: (2017)

Sphingosine Kinase Blockade Leads to Increased Natural Killer T Cell Responses to Mantle Cell Lymphoma
por: Lee, Michael S., et al.
Publicado: (2020)

Feeder Cells at the Interface of Natural Killer Cell Activation, Expansion and Gene Editing
por: Gurney, Mark, et al.
Publicado: (2022)

iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting
por: Goldenson, Benjamin H., et al.
Publicado: (2022)

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
por: Chiu, Yen-Ling, et al.
Publicado: (2011)

Present and Future of Allogeneic Natural Killer Cell Therapy
por: Lim, Okjae, et al.
Publicado: (2015)

Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
por: Hermanson, David L., et al.
Publicado: (2015)

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
por: Mehta, Rohtesh S., et al.
Publicado: (2018)

Antigens of Mycobacterium tuberculosis Stimulate CXCR6+ Natural Killer Cells
por: Choreño-Parra, José Alberto, et al.
Publicado: (2020)

Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions
por: Wang, Zixi, et al.
Publicado: (2020)

Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
por: Shah, Nina, et al.
Publicado: (2013)

Homing of Antigen-Presenting Cells in Head Kidney and Spleen – Salmon Head Kidney Hosts Diverse APC Types
por: Iliev, Dimitar B., et al.
Publicado: (2013)

Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy
por: Kang, Lin, et al.
Publicado: (2013)

Novel lipid antigens for NKT cells in cancer
por: Lee, Michael S., et al.
Publicado: (2023)

The Influence of Invariant Natural Killer T Cells on Humoral Immunity to T-Dependent and -Independent Antigens
por: Lang, Mark L.
Publicado: (2018)

Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation
por: Nabekura, Tsukasa, et al.
Publicado: (2014)

Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation
por: Fielding, Ceri A, et al.
Publicado: (2017)

Natural Killer Cells in Asthma
por: Karimi, Khalil, et al.
Publicado: (2013)

Uterine Natural Killer Cells
por: Sojka, Dorothy K., et al.
Publicado: (2019)

Natural Killer Cells in the Lungs
por: Cong, Jingjing, et al.
Publicado: (2019)

Ena/VASP Protein-Mediated Actin Polymerization Contributes to Naïve CD8(+) T Cell Activation and Expansion by Promoting T Cell–APC Interactions In Vivo
por: Waldman, Monique M., et al.
Publicado: (2022)

From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies
por: Tabellini, Giovanna, et al.
Publicado: (2019)

Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells
por: Ismail, Nurul Izza
Publicado: (2023)

Natural Killer Cells as Key Mediators in Type I Diabetes Immunopathology
por: Gardner, Graeme, et al.
Publicado: (2021)

Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus Infections
por: Malone, David F. G., et al.
Publicado: (2017)

Impact of the Variable Killer Ig-Like Receptor–Human Leukocyte Antigen Interactions on Natural Killer Cell Cytotoxicity Toward Foreign CD4 T Cells
por: Hens, Jef, et al.
Publicado: (2018)

Natural Killer Cells and Liver Fibrosis
por: Fasbender, Frank, et al.
Publicado: (2016)

Natural Killer Cells in Antifungal Immunity
por: Schmidt, Stanislaw, et al.
Publicado: (2017)

Unraveling Natural Killer T-Cells Development
por: Bennstein, Sabrina Bianca
Publicado: (2018)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Deciphering Natural Killer Cell Homeostasis
por: Pfefferle, Aline, et al.
Publicado: (2020)

Mechanosensation and Mechanotransduction in Natural Killer Cells
por: Santoni, Giorgio, et al.
Publicado: (2021)

GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells
por: Liu, Enli, et al.
Publicado: (2021)

NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells
por: Foltz, Jennifer A., et al.
Publicado: (2016)

Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors–Human Leukocyte Antigen Ligand Mismatch and Activation Receptor–Ligand Interactions
por: Haspels, Heleen Neeltje, et al.
Publicado: (2018)

Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers
por: Messaoudene, Meriem, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0juogsjon1bvoeivb7gsfou0us